.avif)
CSL Vifor Email Format
Biotechnology Research
・
25,001-50,000 employees
・
Melbourne, VIC, Australia
CSL Vifor is a global biopharmaceutical company that develops and delivers lifesaving medicines for haemophilia, immune deficiencies, iron deficiency, dialysis, and nephrology across more than 100 countries.
Search our verified sources for decision-makers, emails, and titles.
Start searching
VERIFIED BY CLAY
first.last@viforpharma.com
Company Overview
Industry
Biotechnology Research
Founded
1916
Headquarters
Melbourne, VIC, Australia
Revenue
$10B-$25B
FUNDING Stage
Public
Website
Key Executives
Hervé Gisserot (Senior Vice President and General Manager, CSL Vifor), Alex Sigalas (Head of Finance), Mary Oates (Executive Vice President and Chief Operating Officer)
Tech Stack
Key Executives
4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified
Frequently Asked Questions
What is the email format of CSL Vifor?
CSL Vifor uses the first.last format, so Jane Smith would be jane.smith@viforpharma.com.
What therapeutic areas does CSL Vifor focus on?
CSL Vifor focuses on two core therapeutic areas: iron deficiency and iron deficiency anaemia (spanning heart failure, kidney disease, and women's health), and nephrology, covering all stages of chronic kidney disease including dialysis.
Which products make up the CSL Vifor nephrology portfolio?
The CSL Vifor nephrology portfolio includes Veltassa for hyperkalemia, Korsuva (Kapruvia) for chronic kidney disease-associated pruritus in hemodialysis patients, Filspari for IgA nephropathy, Tavneos for ANCA-associated vasculitis, Velphoro, Mircera, and Retacrit.
How does CSL Vifor reach dialysis patients through its joint venture with Fresenius Medical Care?
CSL Vifor holds a 55% stake in Vifor Fresenius Medical Care Renal Pharma (VFMCRP), a joint venture with Fresenius Medical Care that gives CSL Vifor direct access to dialysis patients across thousands of clinics worldwide.
How widely is CSL Vifor's Ferinject approved for treating iron deficiency?
Ferinject (marketed as Injectafer in the US) has received marketing authorization in 87 countries. If you are building a prospect list of CSL Vifor contacts across these markets, a tool like Clay can help enrich and verify those records.
Get access to more people and company data using Clay
Leverage the power of 100+ data providers for industry-leading data coverage & quality.
4.9 rating